ArticleCureus2026

Effect of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists and Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitors on Atherosclerotic Cardiovascular Risk Among Patients With Type 2 Diabetes in Primary Health Care Settings in Jeddah, Saudi Arabia.

Rahaf A Ljohani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.